Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma

INTRODUCTION: Glioblastoma (GBM) is identified as a lethal malignant tumor derived from the nervous system. Despite the standard clinical strategy including maximum surgical resection, temozolomide (TMZ) chemotherapy, and radiotherapy, the median survival of GBM patients remains <15 months. Accum...

Descripción completa

Detalles Bibliográficos
Autores principales: Alafate, Wahafu, Li, Xiaodong, Zuo, Jie, Zhang, Hua, Xiang, Jianyang, Wu, Wei, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080429/
https://www.ncbi.nlm.nih.gov/pubmed/32187449
http://dx.doi.org/10.1111/cns.13297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080429/
https://www.ncbi.nlm.nih.gov/pubmed/32187449
http://dx.doi.org/10.1111/cns.13297

Ejemplares similares